Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457626 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension
A Phase 3 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 66
- Enrollment target
NCT00457626 is a Phase 3 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 66 participants.
The verdict
NCT00457626, a Phase 3 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy, safety and tolerability of long-term use (up to 18 weeks) of valsartan in children 6 months to 5 years old with hypertension.
Interventions
- DRUG Valsartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2007-04-09 |
| Est. Completion | 2009-05-25 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00457626
The ClinicalTrials.gov registry entry for NCT00457626 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valsartan is the first listed.
NCT00457626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00457626 about?
NCT00457626 is a clinical study titled "A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension". The purpose of this study is to evaluate the efficacy, safety and tolerability of long-term use (up to 18 weeks) of valsartan in children 6 months to 5 years old with hypertension.
What is the current status of trial NCT00457626?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 66 participants. The study started on 2007-04-09. Estimated completion is 2009-05-25.
What interventions are being tested in trial NCT00457626?
The interventions under investigation include: Valsartan (DRUG).
Who is sponsoring clinical trial NCT00457626?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.